Medexus Pharmaceuticals Inc.

TSE: CA:MDP

GO

Quotes are delayed by 15 min

Jan 31, 2023, 11:02 a.m.

MDP
/zigman2/quotes/208555543/delayed

$

1.88

Change

+0.02 +1.08%

Volume

Volume 2,501

Quotes are delayed by 15 min

/zigman2/quotes/208555543/delayed

Previous close

$ 1.86

$ 1.88

Change

+0.02 +1.08%

Day low

Day high

$1.88

$1.92

Open

52 week low

52 week high

$0.88

$3.45

Open

Peter A. van der Velden

Presently, Peter A. van der Velden is Chairman of Medexus Pharmaceuticals, Inc. and Managing General Partner at Lumira Capital Investment Management, Inc. He is also on the board of 6 other companies.

In the past he occupied the position of Partner at Bedford Capital Corp., Managing Partner at Taurus Capital Partners LLC, Vice President-Business Development for Hyal Pharmaceutical Corp. and President & Director at Canada's Venture Capital & Private Equity Association.

He received an MBA from The Schulich School of Business and an undergraduate degree and a graduate degree from Queen's University.

Transactions

Date Shares Transaction Value
02/23/2021 290,339   1,953,981
02/23/2021 9,661   65,018
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0

Officers and Executives

Mr. Kenneth d’Entremont
Chief Executive Officer & Director
Mr. Richard Labelle
VP-Allergy, Pediatric & OTC Portfolios
Mr. Marcel Konrad
Chief Financial Officer
Mr. Ian C. Wildgoose Brown
Secretary & General Counsel
Mr. Peter A. van der Velden
Chairman
Ms. Adele M. Gulfo
Independent Director
Mr. Michael Peter Mueller
Independent Director
Mr. Benoit Gravel
Independent Director
Mr. Stephen Nelson
Independent Director
Link to MarketWatch's Slice.